Stock listing

IBRX Stock Price, News, Filings & Events — Immunitybio, Inc.

Selected listing: IBRX · NASDAQ · USD · US

IBRX:NASDAQ is the primary listing for Immunitybio, Inc., a U.S.-based public company with a market capitalization of approximately $8.04 billion. The company specializes in developing innovative immunotherapy solutions aimed at treating various diseases. Immunitybio's focus on advancing healthcare through cutting-edge research highlights its significant role in the biotechnology sector. Recent news and filings may provide insights into its ongoing projects and market developments.

IBRX:NASDAQUSDUSUpdated July 31, 2026
Immunitybio, Inc. logo
Ticker
IBRX:NASDAQ
Asset type
Stock
Market cap
$7.51B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Immunitybio, Inc. IBRX:NASDAQ stock context

IBRX:NASDAQ is the primary listing for Immunitybio, Inc., a U.S.-based public company with a market capitalization of approximately $8.04 billion. The company specializes in developing innovative immunotherapy solutions aimed at treating various diseases. Immunitybio's focus on advancing healthcare through cutting-edge research highlights its significant role in the biotechnology sector. Recent news and filings may provide insights into its ongoing projects and market developments.

Research Immunitybio, Inc.

Alternate listings